A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial-Reference-Cited by-同舟云学术

A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial

Published:2016-09-06 Issue:9 Volume:18 Page:e238
ISSN:1438-8871
Container-title:Journal of Medical Internet Research
language:en
Short-container-title:J Med Internet Res

Author:

Egbring Marco^ORCID,Far Elmira^ORCID,Roos Malgorzata^ORCID,Dietrich Michael^ORCID,Brauchbar Mathis^ORCID,Kullak-Ublick Gerd A^ORCID,Trojan Andreas^ORCID

Publisher

JMIR Publications Inc.

Subject

Health Informatics

Reference12 articles.

1. A Telemedicine-Based Intervention Reduces the Frequency and Severity of COPD Exacerbation Symptoms: A Randomized, Controlled Trial

2. The Patient Remote Intervention and Symptom Management System (PRISMS) – a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial

3. Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic

4. Side Effects of Adjuvant Treatment of Breast Cancer

5. Toxicity and response criteria of the Eastern Cooperative Oncology Group

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data;JMIR Formative Research;2024-05-06

2. Digital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled Trial;Journal of Medical Internet Research;2024-04-25

3. Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes;JMIR Cancer;2024-04-04

4. A Mobile Applet for Assessing Medication Adherence and Managing Adverse Drug Reactions Among Patients With Cancer: Usability and Utility Study;JMIR Formative Research;2024-02-29

5. Assessing the Quality, Privacy, and Security of Breast Cancer Apps for Arabic Speakers: Systematic Search and Review of Smartphone Apps;JMIR Cancer;2024-01-16